Avalo Therapeutics (AVTX) EBT Margin Growth (3y) (2019 - 2025)
Avalo Therapeutics (AVTX) EBT Margin Growth (3y) (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,756.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
441.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Avalo Therapeutics |
295.77 Mn |
295.77 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-2.19 Mn |
| Dec 31, 2024 |
-960,343.00 |
| Sep 30, 2024 |
1.05 Mn |
| Dec 31, 2023 |
-34,133.00 |
| Sep 30, 2023 |
-101,853.00 |
| Jun 30, 2023 |
-28,057.00 |
| Mar 31, 2023 |
-121,132.00 |
| Dec 31, 2022 |
-11,984.00 |
| Sep 30, 2022 |
14,899.00 |
| Jun 30, 2022 |
-107,779.00 |
| Mar 31, 2022 |
-168,381.00 |
| Dec 31, 2021 |
-875,752.00 |
| Sep 30, 2021 |
-69,104.00 |
| Jun 30, 2021 |
-39,262.00 |
| Mar 31, 2021 |
-637,543.00 |
| Dec 31, 2020 |
-86,282.00 |
| Sep 30, 2020 |
-128,101.00 |
| Jun 30, 2020 |
14,722.00 |
| Mar 31, 2020 |
-37,248.00 |
| Dec 31, 2019 |
-7,397.00 |
